Secondary Prevention of Cerebral Infarction Epidemiological Study on Cerebral Microbleeds
Not Applicable
- Conditions
- cerebral infaction
- Registration Number
- JPRN-UMIN000001230
- Lead Sponsor
- SCIENCE Study Protocol Comittee
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 4000
Inclusion Criteria
Not provided
Exclusion Criteria
recurred symptomatic cerebral infarction medicatin of antiplatelet drugs before onset moyamoya disease, AVM, AN, dural AVF previous cerebral contusion previous craniotomy and/or burr hole surgery future surgery and/or intervention for brain and heart previous symptomatic cerebral hemorrhage, other hemorrhagic disease, coagulopathy present malignancy platelet count<10000/m3 liver dysfunction (AST>100IU/L, ALT>100IU/L) renal dysfunction (Cre>3mg/dl) future moving, diffculties for follow-up amyloid angiopathy participants in other intervening clinical research
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method symptomatic cerebral infarction and symptomatic cerebral hemorrhage
- Secondary Outcome Measures
Name Time Method number of cerebral microbleeds, Grade of DWMH and PVH, ADL, event by antiplatelet drugs, symptom of upper GI and QOL, other cerebrovascular event, cardiovascular event, death